104
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Testing the Sensitivity of Conjunctival Swabs from Confirmed COVID-19 Patients

, , , ORCID Icon, , , , , & ORCID Icon show all
Pages 2489-2496 | Published online: 15 Jun 2021

References

  • Bozkurt B, Eğrilmez S, Şengör T, Yıldırım Ö, Irkeç M. The COVID-19 pandemic: clinical information for ophthalmologists. Turk J Ophthalmol. 2020;50(2):59–63. doi:10.4274/tjo.galenos.2020.29805
  • Zou P, Huo D, Li M. The impact of the COVID- 19 pandemic on firms: a survey in Guangdong Province, China. Glob Health Res Policy. 2020;5:41. doi:10.1186/s41256-020-00166-z
  • Kharel Sitaula R, Khatri A, Janani MK, et al. Unfolding COVID-19: lessons-in-learning in ophthalmology. Clin Ophthalmol. 2020;14:2807–2820. doi:10.2147/OPTH.S259857
  • Dawood AA. Transmission of SARS CoV-2 virus through the ocular mucosa worth taking precautions. Vacunas (English Edition). 2021;22:56–57. doi:10.1016/j.vacune.2021.01.007
  • Yuan H, Chan Y, Xin-Feng X, Wei X, Shu-Wen L. Structural and functional properties of SARS-CoV-2 spike protein: potential antiviral drug development for COVID-19. Acta Pharmacol Sin. 2020;41:1141–1149. doi:10.1038/s41401-020-0485-4
  • Ho D, Low R, Tong L, Gupta V, Veeraraghavan A, Agrawal RCOVID-19. and the ocular surface: a review of transmission and manifestations. Ocul Immunol Inflamm. 2020;28:726–734. doi:10.1080/09273948.2020.1772313
  • Hu K, Patel J, Patel BC. 2021. Ophthalmic manifestations of coronavirus (COVID-19). In: Abai B, Abu-Ghosh A, editors. StatPearls. Treasure Island, FL: StatPearls Publishing. Available from https://www.ncbi.nlm.nih.gov/books/NBK556093. Accessed June 4, 2021.
  • Lu CW, Liu XF, Jia ZF. 2019‐nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395:e39. doi:10.1016/S0140-6736(20)30313-5
  • Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARSCoV-2 infection. J Med Virol. 2020;92:589–594. doi:10.1002/jmv.25725
  • Seah IYJ, Anderson DE, Kang AEZ, et al. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020;127:977–979. doi:10.1016/j.ophtha.2020.03.026
  • Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138:575–578. doi:10.1001/jamaophthalmol.2020.1291
  • Zhang X, Chen X, Chen L, et al. The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf. 2020;18:360–362. doi:10.1016/j.tos.2020.03.010
  • Zhou Y, Zeng Y, Tong Y, Chen C. Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. medRxiv. 2020;20021956. doi:10.1101/2020.02.11.20021956
  • Chen L, Liu M, Zhang Z, et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol. 2020;104(6):748–751.
  • Colavita F, Lapa D, Carletti F, et al. SARSCoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection. Ann Intern Med. 2020;173:242–243. doi:10.7326/M20-1176
  • Mahmoud H, Ammar H, El Rashidy A, Ali AH, Hefny HM, Mounir A. Assessment of coronavirus in the conjunctival tears and secretions in patients with SARS-CoV-2 infection in Sohag Province, Egypt. Clin Ophthalmol (Auckland, NZ). 2020;14:2701–2708. doi:10.2147/OPTH.S270006
  • Kumar K, Prakash AA, Gangasagara SB, et al. Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients. Indian J Ophthalmol. 2020;68:1015–1017. doi:10.4103/ijo.IJO_1287_20
  • Li X, Chan JF, Li KK, et al. Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms. Infection. 2020:1–9. doi:10.1007/s15010-020-01524-2.
  • Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020;55:e125–9.
  • Khavandi S, Tabibzadeh E, Naderan M, Shoar S. Corona virus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic. Cont Lens Anterior Eye. 2020;43:211–212.
  • Ye Y, Song Y, Yan M, et al. Novel coronavirus pneumonia combined with conjunctivitis: three cases report. Chin J Exp Ophthalmol. 2020;38:242–244. doi:10.3760/cma.j.issn.2095-0160.2020.0006
  • Hu Y, Chen T, Liu M, et al. Positive detection of SARS- CoV-2 combined HSV1 and HHV6B virus nucleic acid in tear and conjunctival secretions of a non-conjunctivitis COVID-19 patient with obstruction of common lacrimal duct. Acta Ophthalmol. 2020. doi:10.1111/aos.14456
  • Ulhaq ZS, Soraya GV. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefes Arch Clin Exp Ophthalmol. 2020;258:1351–1352. doi:10.1007/s00417-020-04695-8
  • Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival SARS-COV-2 in COVID-19 patients. Ophthalmology. 2020. doi:10.1016/j.ophtha.2020.04.028
  • Deng W, Bao L, Gao H, et al. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques. bioRxiv. 2020. doi:10.1101/2020.03.13.990036
  • Güemes-Villahoz N, Burgos-Blasco B, Vidal-Villegas B, et al. Novel insights into the transmission of SARS-CoV-2 through the ocular surface and its detection in tears and conjunctival secretions: a review. Adv Ther. 2020;37(10):4086–4095. doi:10.1007/s12325-020-01442-7
  • Napoli PE, Nioi M, d’Aloja E, Fossarello M. The ocular surface and the coronavirus disease 2019: does a dual ‘ocular route’ exist? J Clin Med. 2020;9(5):1269. doi:10.3390/jcm9051269
  • Napoli PE, Nioi M, d’Aloja E, Fossarello M. Safety recommendations and medical liability in ocular surgery during the COVID-19 pandemic: an unsolved dilemma. J Clin Med. 2020;9(5):1403. doi:10.3390/jcm9051403